Clinical trial

Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer

NCT00515112

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2007-07-01

PhasePHASE2

Study timeline

Study start (unknown)2007-07-01Date precision: month

Registry last updated2014-06-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

AndroGelDRUG · verified · RxNorm: Androgel

placeboDRUG

Sponsors & collaborators

University of Chicagolead sponsor

Solvay Pharmaceuticalscollaborator

Mapped research locations

ChicagoIllinois, United States2 HoustonTexas, United States1 Los AngelesCalifornia, United States1 BaltimoreMaryland, United States1 AuroraColorado, United States1 MilwaukeeWisconsin, United States1 PeoriaIllinois, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00515112 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.